News
The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback